
Danaher Corporation DHR
€ 178.57
0.53%
Danaher Corporation Finanzkreislauf | DHR
Finanzkreislauf Jährlich Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.5 | 83.5 | 93.5 | 79.1 | 72.3 | 65.9 | 70.3 | 72.2 | 85 | 79.7 | 72.1 | 64.9 | 66.1 | 76.3 | 85.7 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 93.5 | 64.9 | 76.3 |
Finanzkreislauf Vierteljährlich Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84.3 | - | - | - | - | 76 | 67.6 | - | -12.8 | 26.6 | 65.5 | - | -7.61 | -6.79 | 29.5 | 59.8 | -4.84 | -4.96 | 33.5 | 55.5 | -6.66 | -8.3 | 37.4 | 63.2 | 86.2 | 83.3 | 84.5 | 63.4 | 81.5 | 79.5 | 82.3 | 63 | 96.7 | 74.8 | 72.1 | 60.2 | 66.9 | 65.1 | 66.8 | 61 | 67.7 | 66.7 | 74.8 | 59.9 | 78.9 | 76.6 | 80.5 | 59 | 77.1 | 95.6 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 96.7 | -12.8 | 56.2 |
Finanzkreislauf anderer Aktien in der Diagnostik & Forschung
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 288.5 | 0.54 % | $ 14.3 B | ||
|
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | ||
|
DarioHealth Corp.
DRIO
|
115 | $ 7.24 | 3.72 % | $ 28.8 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
2.11 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 237.14 | 2.07 % | $ 26.3 B | ||
|
DexCom
DXCM
|
134 | $ 87.9 | 0.02 % | $ 34.3 B | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
52.5 | $ 164.85 | 0.78 % | $ 12.9 B | ||
|
Soleno Therapeutics
SLNO
|
-398 | - | - | $ 2.69 B | ||
|
Psychemedics Corporation
PMD
|
39.8 | - | -1.84 % | $ 15.3 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Syneos Health
SYNH
|
-9.97 | - | - | $ 4.46 B | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 326.89 | 0.29 % | $ 27.2 B | ||
|
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
86.4 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
1.68 | - | -16.95 % | $ 1.54 M | ||
|
T2 Biosystems
TTOO
|
91.3 | - | -39.35 % | $ 313 K | ||
|
Anixa Biosciences
ANIX
|
385 | $ 3.07 | 0.66 % | $ 99.6 K | ||
|
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | ||
|
Meridian Bioscience
VIVO
|
201 | - | - | $ 1.49 B | ||
|
Quotient Limited
QTNT
|
325 | - | -11.32 % | $ 1.1 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 345.26 | 0.11 % | $ 27.7 B | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 3.18 | 1.57 % | $ 294 M | ||
|
ENDRA Life Sciences
NDRA
|
-1.24 K | $ 6.05 | 6.51 % | $ 4.76 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 21.53 | 1.32 % | $ 482 M | ||
|
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M | ||
|
Interpace Biosciences
IDXG
|
62.9 | $ 1.45 | 2.11 % | $ 6.41 M | ||
|
OPKO Health
OPK
|
272 | $ 1.64 | 1.86 % | $ 1.23 B | ||
|
Pacific Biosciences of California
PACB
|
185 | $ 1.35 | 3.85 % | $ 405 M | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 267.77 | 2.95 % | $ 46 B | ||
|
Surmodics
SRDX
|
169 | - | - | $ 608 M | ||
|
Personalis
PSNL
|
-1.89 | $ 17.2 | 2.2 % | $ 1.53 B | ||
|
Quidel Corporation
QDEL
|
68.4 | $ 13.97 | 0.29 % | $ 588 M |